✦ LIBER ✦

Remission induction in acute myelogenous leukemia using cytosine arabinoside synchronization: A southwest oncology group study

✍ Scribed by Steuber, C. Philip ;Humphrey, G. Bennett ;McMillan, Campbell W. ;Vietti, Teresa J.

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 353 KB
Volume: 4
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950040410

No coin nor oath required. For personal study only.

✦ Synopsis

The use of cytosine arabinoside (Ara-C) infused at kinetically suggested intervals is reported in 40 pediatric patients with acute myelogenous leukemia (AML) and its subtypes. Response was observed in 17 of the 34 evaluable patients. However, the severe, often fatal effects of the regimen prevent its recommendation as a standard induction regimen in AML in children.

📜 SIMILAR VOLUMES

Three dose regimens of adriamycin for in

Three dose regimens of adriamycin for induction of remission in acute leukemia in children: A Southwest oncology group study

✍ Starling, K. A. ;Berry, D. H. ;Britton, H. A. ;Humphrey, G. B. ;Vats, T. ;Ragab, 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

## Abstract Three therapeutic regimens (6‐hr intervals for 6 doses daily for 3 days, and a single infusion) utilizing the same total dose of adriamycin for the induction of remission in children with late‐stage acute leukemia were evaluated in 150 patients. Complete remission rates were 15%, 28%, a

Teniposide (VM-26) and continuous infusi

Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study

✍ Judith Ochs; Gaston K. Rivera; Brad H. Pollock; George Buchanan; William Crist; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Treatment of acute myelogenous leukemia

Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: A southwest oncology group study

✍ Dr. Carolyn L. Bigelow; Kenneth Kopecky; Joe C. Files; David Head; David A. Lips 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 3 views

Remission induction and continuation the

Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A pediatric oncology group study

✍ S. J. Culbert; J. J. Shuster; V. J. Land; M. D. Wharam; P. R. M. Thomas; R. Nits 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Impact of the timing of triple intrathec

Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: A pediatric oncology group study

✍ Hvizdala, Eva ;Berry, D. H. ;Chen, Timothy ;Dyment, Paul G. ;Kim, Tae H. ;Steube 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB